Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: A population-based study

Acta Oncologica

Volumn 52, Issue 8, 2013, Pages 1682-1690

  Iachetta, Francesco ^a   Reggiani Bonetti, Luca ^a,c   Marcheselli, Luigi ^a   Di Gregorio, Carmela ^a   Cirilli, Claudia ^a   Messinese, Simona ^a   Cervo, Gian L ^a   Postiglione, Raffaella ^a   Di Emidio, Katia ^a   Pedroni, Monica ^a   Longinotti, Ernesto ^b   Federico, Massimo ^a   Ponz De Leon, Maurizio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b New Civil S Agostino Estense Hospital   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; CLINICAL EVALUATION; COLORECTAL CANCER; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; ITALY; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SURVIVAL RATE; CANCER CHEMOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; HEMICOLECTOMY; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; PERINEURAL INVASION; PREOPERATIVE RADIOTHERAPY; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM RESECTION; TOTAL COLON RESECTION; VERY ELDERLY;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LYMPH NODES; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE;

EID: 84885465772     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.808376     Document Type: Article

References (33)

1. Stocchi L, Fazio VW, Lavery I, Hammel J. Individual surgeon, pathologist, and other factors affecting lymph node harvest in stage II colon carcinoma. Is a minimum of 12 examined lymph nodes sufficient? Ann Surg Oncol 2011; 18: 405-12.
2. Choi HK, Law WL, Poon JT. The optimal number of lymph nodes examined in stage II colorectal cancer and its impact of on outcomes. BMC Cancer 2010; 10: 267.
3. Swanson RS, Compton CC, Stewart AK, Bland KL. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol 2003; 10: 65-71.
4. Sarli L, Bader G, Iusco D, Salvemini C, Mauro DD, Mazzeo A, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 2005; 41: 272-9.
5. Vather R, Sammour T, Kahokehr A, Connolly A, Hill A. Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: A national study. Ann Surg Oncol 2009; 16: 585-93.
6. Chen HH, Chakravarty KD, Wang JY, Changchien CR, Tang R. Pathological examination of 12 regional lymph nodes and long-term survival in stages I-III colon cancer patients: An analysis of 2, 056 consecutive patients in two branches of same institution. Int J Colorectal Dis 2010; 25: 1333-41.
7. Prandi M, Lionetto R, Bini A, Francioni G, Accarpio G, Anfossi A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: Results of a secondary analysis of a large scale adjuvant trial. Ann Surg 2002; 235: 458-63.
8. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer V A. Lymph node evaluation and survival after curative resection of colon cancer: Systematic review. J Natl Cancer Inst 2007; 99: 433-41.
9. Peeples C, Shellnut J, Wasvary H, Riggs T, Sacksner J. Predictive factors affecting survival in stage II colorectal cancer: Is lymph node harvesting relevant? Dis Colon Rectum 2010; 53: 1517-23.
10. Specifications of the National Voluntary Consensus Standards for Quality of Cancer Care, Appendix A. National Quality Forum, 2009. Available from: http://www.qualityforum.org/pubblications/2009/05/National-Volun-tary-Consensus- Standards-for-Quality-of-Cancer-Care. aspx. [cited 2009 Nov 13].
11. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, et al. National Cancer Institute Expert Panel. Guidelines 2000 for colon and rectal cancer surgery. National Cancer Institute Expert Panel. J Natl Cancer Inst 2001; 93:583-96.
12. Scott KWM, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg 1989; 76: 1165-7.
13. Wu Y, Takkenberg JJM, Grunkemeier GL. Measuring follow-up completeness. Ann Thorac Surg 2008; 85: 1155-7.
14. Hamilton SR, Bosman FT, Boffetta P. Carcinoma of the colon and rectum. In: Bosman FT, Carneiro F, Hruban RH, Theise ND, editors. WHO classification of tumor of the digestive system, 4th ed. Lyon: IARC Press; 2009. p 133-8.
15. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer staging manual, 7th ed. Springer: New York; 2009.
16. Kaplan EL, Meier P. Non parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
17. Cox D. Regression models and life tables. J R Stat Soc B 1972; 34: 187-202.
18. Schoenfeld D. Partial residuals for proportional hazard regression model. Biometrika 1982; 69: 239-41.
19. Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics 1992; 48: 73-85.
20. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years: Recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 2002; 26: 179-89.
21. Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton C, Benson AB 3rd, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001; 19: 157-63.
22. Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G, et al. Lymph node recovery from colorectal tumour specimens: Recommendation for a minimum number of lymph nodes to be examined. World J Surg 2002; 26: 384-9.
23. Tsai CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BW, et al. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer 2011; 117: 3713-22.
24. Vather R, Sammour T, Zargar-Shoshtari K, Metcalf P, Connolly A, Hill A. Lymph node examination as a predictor of long term outcome in Dukes B colon cancer. Int J Color-ectal Dis 2009; 24: 283-8.
25. La Torre M, Lorenzon L, Pilozzi E, Barucca V, Cavallini M, Ziparo V, et al. Number of harvested lymph nodes is the main prognostic factor in Stage IIa colorectal cancer patients. J Surg Oncol 2012; 106: 469-74.
26. Ko CY, Chang JT, Chaudhry S, Kominski G. Are highvolume surgeons and hospitals the most important predictors of in-hospital outcome for colon cancer resection? Surgery 2002; 132: 268-73.
27. Wright FC, Law CH, Last L, Khalifa M, Arnaout A, Naseer Z, et al. Lymph node retrieval and assessment in stage II colorectal cancer: A population-based study. Ann Surg Oncol 2003; 10: 903-9.
28. Evans MD, Barton K, Rees A, Stamatakis JD, Karandikar SS. The impact of surgeon and pathologist on lymph node retrieval in colorectal cancer and its impact on survival for patients with Dukes ' stage B disease. Colorectal Dis 2008; 10: 157-64.
29. Ratto C, Sofo L, Ippoliti M, Merico M, Bossola M, Vecchio FM, et al. Accurate lymph-node detection in color-ectal specimens resected for cancer is of prognostic signifi-cance. Dis Colon Rectum 1999; 42: 143-54.
30. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: A population-based study. J Natl Cancer Inst 2005; 97: 219-25.
31. Johnson PM, Malatjalian D, Porter GA. Adequacy for nodal harvest in colorectal cancer: A consecutive cohort study. J Gastrointest Surg 2002; 6: 883-8.
32. Carloss H, Huang B, Cohen A, Carloss E, Wyatt S, Tucker T. The impact of number of lymph nodes removed on five-year survival in stage II colon and rectal cancer. J Ky Med Assoc 2004; 102: 345-7.
33. Bui L, Rempel E, Reeson D, Simunovic M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: A population-based study. J Surg Oncol 2006; 93: 439-45.